Healthcare Professional Blog

Education Library


ESC 2023: Predictors of 90-day Outcomes from York Analysis

Vasileios Panoulas, MD, discusses a pooled analysis of factors predicting outcomes at 90 days in high-risk PCI patients.

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Ergebnisse filtern





March 15, 2023

ECMO-CS Trial: VA ECMO in Rapidly Deteriorating or Severe Cardiogenic Shock

Prof. Jan Belohlavek, MD, discusses ECMO CS trial results comparing immediate VA ECMO with conservative therapy allowing VA ECMO downstream in severe cardiogenic shock.

January 24, 2023

Specific Clinical Vignettes in High-Risk Protected Percutaneous Coronary Intervention

This article presents 3 case vignettes that provide practical insights and reinforce best practices. The authors emphasize that several cardiac and patient-related factors come into play when considering patients for Protected percutaneous coronary intervention (PCI).

January 24, 2023

Optimal Bail-out and Complication Management Strategies in Protected High-Risk Percutaneous Coronary Intervention With the Impella Heart Pump

In this article the authors describe techniques for Impella heart pump removal with or without pre-closure and discuss how to prevent and manage complications associated with large-bore femoral access.

January 24, 2023

Handling High-Risk Patients in the Catheterization Laboratory

This article describes how the interventional cardiology team handles high-risk patients in the cath lab, from procedural preparation and planning through procedural monitoring, as well as weaning strategies and access site management.

January 24, 2023

Defining the Optimal Revascularization Strategy During Protected High-Risk Procedures With Impella Heart Pumps

This article explores optimal revascularization strategies for patients undergoing Protected PCI.

January 24, 2023

What Is Known in Pre-, Peri-, and Post-Procedural Anticoagulation in Micro-Axial Flow Pump Protected Percutaneous Coronary Intervention?

“The precarious balance between bleeding and thrombosis in patients with p-LVAD support is often the primary reason that patients’ outcomes are jeopardized,” write the authors of this article, which discusses anticoagulation strategies and anticoagulant management in the setting of Protected PCI.

January 24, 2023

Standardized Pre-Procedural Clinical Workup for Protected Percutaneous Coronary Intervention

This article describes pre-procedural preparation, with a particular focus on imaging techniques for screening and guiding vascular access in patients undergoing Protected PCI.

January 13, 2023

Optimized Patient Selection in High-Risk Protected Percutaneous Coronary Intervention

Patients undergoing elective high-risk PCI are often in critical condition and not candidates for coronary artery bypass graft (CABG) surgery.

January 13, 2023

European Best Practice: A Step Forward to Optimize Impella-Protected Percutaneous Coronary Intervention to Improve Outcome After High-Risk Coronary Interventions

This overview article provides a framework for this series of articles. It addresses European recommendations and best practices for patient management and mechanical circulatory support (MCS)during high risk intervention, highlighting the following topics...

January 9, 2023

Best Practices for Optimizing Impella Use in High-Risk Patients

Prof. Dr. Nikos Werner introduces European best practices for optimizing Protected PCI with Impella heart pumps that were recently published in European Heart Journal Supplements.

December 2, 2022

Burzotta: Status Quo and Outlook for pMCS Strategies

Francesco Burzotta, MD, discusses the use of percutaneous mechanical circulatory support (pMCS) strategies in both high-risk PCI and cardiogenic shock.

October 27, 2022

Christophe Vandenbriele: Anticoagulation Challenges in Patiens Supported with Impella® Heart Pumps

Dr. Pal Soos interviews Prof. Dr. Christophe Vandenbriele, a cardiologist and intensivist from UZ Leuven (Belgium) and research fellow at Royal Brompton Hospital in London. Dr.

October 20, 2022

Vasileios Panoulas, MD: Restoring EF in Daily Clinical Practice

Vasileios Panoulas, MD, presents 3 patient case examples illustrating significant LV improvement with PCI supported with Impella heart pumps.

October 20, 2022

Clinical Trial Update with Chuck Simonton, MD

Chuck Simonton, MD, provides an update on clinical trials including PROTECT III, RESTORE EF, and PROTECT IV RCT.

October 11, 2022

EACTS 2022 on Demand - MCS for PCCS, Structural Heart Disease, and Advanced Cardiogenic Shock

Discover the recordings of our scientific session at EACTS 2022 about "Innovative Strategies for Superior Outcome in Cardiac Surgery Including pMCS Support in Therapy Pathway".

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.


A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.


Discover further resources like brochures, data sheets and indications for use.